Evolved bacterial siderophore-mediated antibiotic cross-protection

Jorth, Peter; Galdino, Anna Clara Milesi; Vaillancourt, Mylène; Celedonio, Diana; Huse, Kristin K.; Doi, Yohei; Lee, Janet

doi:10.21203/rs.3.rs-2644953/v1

Cited by 2 publications

(2 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is often assumed that the evolution of AMR involves a fitness cost, although this has predominantly been tested in lab-evolved strains [15, 85–88]. We found no evidence for collateral sensitivity or trade-offs between resistance and fitness in a CF-like medium for these clinical populations.…”

Section: Discussionmentioning

confidence: 61%

The Role of Hypermutation and Collateral Sensitivity in Antimicrobial Resistance Diversity ofPseudomonas aeruginosaPopulations in Cystic Fibrosis Lung Infection

Vanderwoude

Azimi

Read

et al. 2023

Preprint

View full text Add to dashboard Cite

Pseudomonas aeruginosa is the predominant bacterial pathogen in the cystic fibrosis (CF) lung, establishing a chronic, drug-resistant infection often via a single adapting and diversifying strain. In this study, we collected a bio-repository of 300 isolates of P. aeruginosa from four CF patients to unravel the extent of within-patient genomic diversity in CF lung infection; elucidate the evolutionary processes by which this diversity is generated; and understand how diversification impacts antimicrobial resistance. We found that populations of P. aeruginosa in the CF lung displayed patient specific genomic diversity ranging from 1 to 199 median pairwise SNPs, and 31 to 4,592 total SNPs within a population. Diversification was driven by a combination of de novo mutations, recombination, and variations in gene content, with the highest levels of population diversity associated with the presence of DNA mismatch repair mutants. Populations with higher levels of genomic diversity displayed increased variation in antibiotic resistance phenotypes; however, even populations with lower genomic diversity displayed substantial diversity in resistance profiles. Intriguingly, we found evidence that mutations in DNA mismatch repair can facilitate the evolution of seemingly undesirable traits in vivo, such as increased sensitivity to certain antimicrobials. Overall, our findings highlight that (i) P. aeruginosa genomic population diversity in chronic CF lung infection is highly variable between patients; (ii) hypermutator populations can evolve increased sensitivity to antimicrobials even under apparent antibiotic selection; and that (iii) current methods of single-isolate sampling and susceptibility testing should be re-evaluated in the study of chronic P. aeruginosa infection.

show abstract

Section: Discussionmentioning

confidence: 61%

The Role of Hypermutation and Collateral Sensitivity in Antimicrobial Resistance Diversity ofPseudomonas aeruginosaPopulations in Cystic Fibrosis Lung Infection

Vanderwoude

Azimi

Read

et al. 2023

Preprint

View full text Add to dashboard Cite

show abstract

“…It is often assumed that the evolution of AMR involves a fitness cost, although this has predominantly been tested in lab-evolved strains ( 15 , 85 – 88 ). We found no evidence for collateral sensitivity or trade-offs between resistance and fitness in a CF-like medium for these clinical populations.…”

Section: Discussionmentioning

confidence: 99%

The role of hypermutation and collateral sensitivity in antimicrobial resistance diversity of Pseudomonas aeruginosa populations in cystic fibrosis lung infection

Vanderwoude,

Azimi,

Read

et al. 2024

mBio

View full text Add to dashboard Cite

Pseudomonas aeruginosa is an opportunistic pathogen which causes chronic, drug-resistant lung infections in cystic fibrosis (CF) patients. In this study, we explore the role of genomic diversification and evolutionary trade-offs in antimicrobial resistance (AMR) diversity within P. aeruginosa populations sourced from CF lung infections. We analyzed 300 clinical isolates from four CF patients (75 per patient) and found that genomic diversity is not a consistent indicator of phenotypic AMR diversity. Remarkably, some genetically less diverse populations showed AMR diversity comparable to those with significantly more genetic variation. We also observed that hypermutator strains frequently exhibited increased sensitivity to antimicrobials, contradicting expectations from their treatment histories. Investigating potential evolutionary trade-offs, we found no substantial evidence of collateral sensitivity among aminoglycoside, beta-lactam, or fluoroquinolone antibiotics, nor did we observe trade-offs between AMR and growth in conditions mimicking CF sputum. Our findings suggest that (i) genomic diversity is not a prerequisite for phenotypic AMR diversity, (ii) hypermutator populations may develop increased antimicrobial sensitivity under selection pressure, (iii) collateral sensitivity is not a prominent feature in CF strains, and (iv) resistance to a single antibiotic does not necessarily lead to significant fitness costs. These insights challenge prevailing assumptions about AMR evolution in chronic infections, emphasizing the complexity of bacterial adaptation during infection. IMPORTANCE Upon infection in the cystic fibrosis (CF) lung, Pseudomonas aeruginosa rapidly acquires genetic mutations, especially in genes involved in antimicrobial resistance (AMR), often resulting in diverse, treatment-resistant populations. However, the role of bacterial population diversity within the context of chronic infection is still poorly understood. In this study, we found that hypermutator strains of P. aeruginosa in the CF lung undergoing treatment with tobramycin evolved increased sensitivity to tobramycin relative to non-hypermutators within the same population. This finding suggests that antimicrobial treatment may only exert weak selection pressure on P. aeruginosa populations in the CF lung. We further found no evidence for collateral sensitivity in these clinical populations, suggesting that collateral sensitivity may not be a robust, naturally occurring phenomenon for this microbe.

show abstract

Evolved bacterial siderophore-mediated antibiotic cross-protection

Cited by 2 publications

References 25 publications

The Role of Hypermutation and Collateral Sensitivity in Antimicrobial Resistance Diversity ofPseudomonas aeruginosaPopulations in Cystic Fibrosis Lung Infection

The Role of Hypermutation and Collateral Sensitivity in Antimicrobial Resistance Diversity ofPseudomonas aeruginosaPopulations in Cystic Fibrosis Lung Infection

The role of hypermutation and collateral sensitivity in antimicrobial resistance diversity of Pseudomonas aeruginosa populations in cystic fibrosis lung infection

Contact Info

Product

Resources

About